x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- SeroprevalenceRemove Seroprevalence filter
- EpidemiologyRemove Epidemiology filter
- 2020 - 2022Remove 2020 - 2022 filter
Author
- Araujo-Castillo, Roger V1
- Barbosa, Aguyda Rayany Cavalcante1
- Benites-Peralta, Bruno1
- Carvalho, Nani Oliveira1
- Coia, John Eugenio1
- Cordeiro, Isabelle Bezerra1
- Dos Santos, Rafaella Oliveira1
- Filho, Ivanildo Vieira Pereira1
- Filho, Spartaco Astofi1
- Ganoza, Christian A1
- Johansen, Isik Somuncu1
- Jordão, Maele Ferreira1
- Justesen, Ulrik Stenz1
- Lalwani, Jaila Dias Borges1
- Lalwani, Pritesh1
- Lillevang, Søren Thue1
- Madsen, Jonna Skov1
- Mayta-Tristan, Percy1
- Mogensen, Christian Backer1
- Möller, Sören1
- Neto, Júlio Nino de Souza1
- Núñez-Zapata, Susy Fanny1
- Rodríguez-Morales, Alfonso J1
- Røge, Birgit Thorup1
- Salgado, Bárbara Batista1
Coronavirus (COVID-19) Collection
3 Results
- Research ArticleOpen Access
SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark
International Journal of Infectious DiseasesVol. 112p96–102Published online: September 14, 2021- Sebastian von Huth
- Søren Thue Lillevang
- Birgit Thorup Røge
- Jonna Skov Madsen
- Christian Backer Mogensen
- John Eugenio Coia
- and others
Cited in Scopus: 3Coronavirus disease 2019 (COVID-19) surged as an ongoing worldwide pandemic throughout 2020 (Park et al., 2020; Siordia, 2020). The first Danish cases were reported in late February 2020, and the initial spread of infection most likely originated from ski tourists returning from Northern Italy and Austria (Madsen et al., 2021). The first epidemic wave in Denmark peaked in late March and early April, with 9.2 patients admitted to hospital per 100 000 population (Madsen et al., 2021; Statens Serum Institut 2021). - Research ArticleOpen Access
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study
International Journal of Infectious DiseasesVol. 110p141–150Published online: July 14, 2021- Pritesh Lalwani
- Bárbara Batista Salgado
- Ivanildo Vieira Pereira Filho
- Danielle Severino Sena da Silva
- Thiago Barros do Nascimento de Morais
- Maele Ferreira Jordão
- and others
Cited in Scopus: 13Infectious diseases have a profound impact on humans, particularly vulnerable populations (Fauci and Morens, 2012). The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and a lack of effective treatment and non-pharmaceutical interventions to curb transmission have led to an exponential increase in the burden of coronavirus disease 2019 (COVID-19) worldwide (Hsiang et al., 2020; Kraemer et al., 2020; Bo et al., 2021). - Short CommunicationOpen Access
High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!
International Journal of Infectious DiseasesVol. 109p244–246Published online: July 11, 2021- Susy Fanny Núñez-Zapata
- Bruno Benites-Peralta
- Percy Mayta-Tristan
- Alfonso J. Rodríguez-Morales
Cited in Scopus: 10There has been intense discussion about the importance of reaching herd immunity to achieve global population protection status against SARS-CoV-2/COVID-19. For that reason, vaccination coverage and seroprevalence studies are increasing around the world; some of them have shown an increase in the seroprevalence of different populations. For example, a recent study in Jordan (Sughayer et al., 2021) stated the importance of seroprevalence studies for SARS-CoV-2 infection among healthy blood donors.
